Xianli He

9PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 29, 2026
MYC-Dependent rRNA Catabolism Stress Dictates Survival Heterogeneity of Hepatocellular Carcinoma Cells Under Glutamine Deprivation.

|Apr 04, 2026
Regulating the dormancy of cancer stem cells: a novel approach to preventing cancer relapse.

Qian Wang, Ning Liang, Xiongchao Fang

|Nov 03, 2025
Mitochondria-transliterated ALDH1L1 functions as a feedback regulator of redox homeostasis in cancer cells to enhance the resistance to pro-oxidative therapy.

Dan Wu, Xin Zhao, Caiyu Shi

|Jul 01, 2025
SLC44A2 negatively regulates mitochondrial fatty acid oxidation to suppress colorectal progression by blocking the MUL1-CPT2 interaction.

Ying Yang, Longlong Zheng, Jiaxing He

|Dec 24, 2024
Ovarian cancer-derived TGF-β1 induces cancer-associated adipocytes formation by activating SMAD3/TRIB3 pathway to establish pre-metastatic niche.

Tian Gao, Jibin Li, Tianyi Cheng

|Jan 18, 2022
EDDM3A drives gastric cancer progression by promoting HIF-1α-dependent aerobic glycolysis.

Tao Wu, Ying Yang, Bo Zhang

Pageof 2

Frequent Collaborators

4 joint publications

Nan Wang

3 joint publications

Tao Wu

1 joint publications

Jia-Xing He

1 joint publications

Lijuan Yuan